BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liguori M, Nuzziello N, Introna A, Consiglio A, Licciulli F, D'Errico E, Scarafino A, Distaso E, Simone IL. Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis. Front Mol Neurosci 2018;11:288. [PMID: 30210287 DOI: 10.3389/fnmol.2018.00288] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 11.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang L, Zhang L. MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development. Neurol Sci 2020;41:3569-77. [PMID: 33006054 DOI: 10.1007/s10072-020-04773-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
2 Daneshafrooz N, Joghataei MT, Mehdizadeh M, Alavi A, Barati M, Panahi B, Teimourian S, Zamani B. Identification of let-7f and miR-338 as plasma-based biomarkers for sporadic amyotrophic lateral sclerosis using meta-analysis and empirical validation. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-05067-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nguyen TPN, Kumar M, Fedele E, Bonanno G, Bonifacino T. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases. Int J Mol Sci 2022;23:4718. [PMID: 35563107 DOI: 10.3390/ijms23094718] [Reference Citation Analysis]
4 Giagnorio E, Malacarne C, Mantegazza R, Bonanno S, Marcuzzo S. MyomiRs and their multifaceted regulatory roles in muscle homeostasis and amyotrophic lateral sclerosis. J Cell Sci 2021;134:jcs258349. [PMID: 34137441 DOI: 10.1242/jcs.258349] [Reference Citation Analysis]
5 Nuzziello N, Consiglio A, Viterbo RG, Licciulli F, Liuni S, Trojano M, Liguori M. A Pilot Longitudinal Evaluation of MicroRNAs for Monitoring the Cognitive Impairment in Pediatric Multiple Sclerosis. Applied Sciences 2020;10:8274. [DOI: 10.3390/app10228274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Patti F, Fiore M, Chisari CG, D'Amico E, Lo Fermo S, Toscano S, Copat C, Ferrante M, Zappia M. CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset. Environ Res 2020;188:109820. [PMID: 32615355 DOI: 10.1016/j.envres.2020.109820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Su Z, Ren N, Ling Z, Sheng L, Zhou S, Guo C, Ke Z, Xu T, Qin Z. Differential expression of microRNAs associated with neurodegenerative diseases and diabetic nephropathy in protein l-isoaspartyl methyltransferase-deficient mice. Cell Biol Int 2021. [PMID: 34314072 DOI: 10.1002/cbin.11679] [Reference Citation Analysis]
8 Ding SQ, Chen YQ, Chen J, Wang SN, Duan FX, Shi YJ, Hu JG, Lü HZ. Serum exosomal microRNA transcriptome profiling in subacute spinal cord injured rats. Genomics 2020;112:2092-105. [PMID: 31830526 DOI: 10.1016/j.ygeno.2019.12.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
9 Gowda P, Reddy PH, Kumar S. Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria. Ageing Res Rev 2022;73:101529. [PMID: 34813976 DOI: 10.1016/j.arr.2021.101529] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Ding SQ, Chen YQ, Chen J, Wang SN, Duan FX, Shi YJ, Hu JG, Lü HZ. Serum exosomal microRNA transcriptome profiling in subacute spinal cord injured rats. Genomics 2020;112:5086-100. [PMID: 32919018 DOI: 10.1016/j.ygeno.2019.09.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 De Paola E, Verdile V, Paronetto MP. Dysregulation of microRNA metabolism in motor neuron diseases: Novel biomarkers and potential therapeutics. Noncoding RNA Res 2019;4:15-22. [PMID: 30891533 DOI: 10.1016/j.ncrna.2018.12.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
12 Pregnolato F, Cova L, Doretti A, Bardelli D, Silani V, Bossolasco P. Exosome microRNAs in Amyotrophic Lateral Sclerosis: A Pilot Study. Biomolecules 2021;11:1220. [PMID: 34439885 DOI: 10.3390/biom11081220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chen L, Lu Q, Deng F, Peng S, Yuan J, Liu C, Du X. miR-103a-3p Could Attenuate Sepsis-Induced Liver Injury by Targeting HMGB1. Inflammation 2020;43:2075-86. [PMID: 32556802 DOI: 10.1007/s10753-020-01275-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Staats KA, Borchelt DR, Tansey MG, Wymer J. Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis. Mol Neurodegener 2022;17:11. [PMID: 35073950 DOI: 10.1186/s13024-022-00515-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Rastegar-moghaddam SH, Ebrahimzadeh-bideskan A, Shahba S, Malvandi AM, Mohammadipour A. MicroRNA-22: a Novel and Potent Biological Therapeutics in Neurological Disorders. Mol Neurobiol. [DOI: 10.1007/s12035-022-02769-8] [Reference Citation Analysis]
16 Soliman R, Mousa NO, Rashed HR, Moustafa RR, Hamdi N, Osman A, Fahmy N. Assessment of diagnostic potential of some circulating microRNAs in Amyotrophic Lateral Sclerosis Patients, an Egyptian study. Clin Neurol Neurosurg 2021;208:106883. [PMID: 34454204 DOI: 10.1016/j.clineuro.2021.106883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ge Y, Wang Q, Shao W, Zhao Y, Shi Q, Yuan Q, Cui L. Circulating let-7f-5p improve risk prediction of prostate cancer in patients with benign prostatic hyperplasia. J Cancer 2020;11:4542-9. [PMID: 32489471 DOI: 10.7150/jca.45077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Liguori M, Nuzziello N, Simone M, Amoroso N, Viterbo RG, Tangaro S, Consiglio A, Giordano P, Bellotti R, Trojano M. Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study. Brain Behav 2019;9:e01199. [PMID: 30656857 DOI: 10.1002/brb3.1199] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
19 Bottero V, Santiago JA, Quinn JP, Potashkin JA. Key Disease Mechanisms Linked to Amyotrophic Lateral Sclerosis in Spinal Cord Motor Neurons. Front Mol Neurosci 2022;15:825031. [DOI: 10.3389/fnmol.2022.825031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Watson CN, Belli A, Di Pietro V. Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease. Front Genet 2019;10:364. [PMID: 31080456 DOI: 10.3389/fgene.2019.00364] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 11.7] [Reference Citation Analysis]
21 Takata T, Nonaka W, Iwama H, Kobara H, Deguchi K, Masugata H, Touge T, Miyamoto O, Nakamura T, Itano T, Masaki T. Light exercise without lactate elevation induces ischemic tolerance through the modulation of microRNA in the gerbil hippocampus. Brain Res 2020;1732:146710. [PMID: 32035888 DOI: 10.1016/j.brainres.2020.146710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Xu Y, Hu Y, Xu S, Liu F, Gao Y. Exosomal microRNAs as Potential Biomarkers and Therapeutic Agents for Acute Ischemic Stroke: New Expectations. Front Neurol 2022;12:747380. [DOI: 10.3389/fneur.2021.747380] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
23 Nuzziello N, Liguori M. The MicroRNA Centrism in the Orchestration of Neuroinflammation in Neurodegenerative Diseases. Cells 2019;8:E1193. [PMID: 31581723 DOI: 10.3390/cells8101193] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
24 Paez-Colasante X, Figueroa-Romero C, Rumora AE, Hur J, Mendelson FE, Hayes JM, Backus C, Taubman GF, Heinicke L, Walter NG, Barmada SJ, Sakowski SA, Feldman EL. Cytoplasmic TDP43 Binds microRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis. Front Cell Neurosci 2020;14:117. [PMID: 32477070 DOI: 10.3389/fncel.2020.00117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Viré EA, Mead S. Gene expression and epigenetic markers of prion diseases. Cell Tissue Res 2022. [PMID: 35307791 DOI: 10.1007/s00441-022-03603-2] [Reference Citation Analysis]
26 Banack SA, Dunlop RA, Cox PA. An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: towards a biomarker for amyotrophic lateral sclerosis/motor neuron disease. Open Biol 2020;10:200116. [PMID: 32574550 DOI: 10.1098/rsob.200116] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
27 Dhama K, Latheef SK, Dadar M, Samad HA, Munjal A, Khandia R, Karthik K, Tiwari R, Yatoo MI, Bhatt P, Chakraborty S, Singh KP, Iqbal HMN, Chaicumpa W, Joshi SK. Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values. Front Mol Biosci 2019;6:91. [PMID: 31750312 DOI: 10.3389/fmolb.2019.00091] [Cited by in Crossref: 73] [Cited by in F6Publishing: 59] [Article Influence: 24.3] [Reference Citation Analysis]
28 Wang L, Zhang L. Circulating MicroRNAs as Diagnostic Biomarkers for Motor Neuron Disease. Front Neurosci 2020;14:354. [PMID: 32372911 DOI: 10.3389/fnins.2020.00354] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
29 Nuzziello N, Ciaccia L, Liguori M. Precision Medicine in Neurodegenerative Diseases: Some Promising Tips Coming from the microRNAs' World. Cells 2019;9:E75. [PMID: 31892254 DOI: 10.3390/cells9010075] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
30 Ravnik-Glavač M, Glavač D. Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis. Int J Mol Sci 2020;21:E1714. [PMID: 32138249 DOI: 10.3390/ijms21051714] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
31 Hosaka T, Yamashita T, Tamaoka A, Kwak S. Extracellular RNAs as Biomarkers of Sporadic Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases. Int J Mol Sci 2019;20:E3148. [PMID: 31252669 DOI: 10.3390/ijms20133148] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
32 Christoforidou E, Joilin G, Hafezparast M. Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis. J Neuroinflammation 2020;17:135. [PMID: 32345319 DOI: 10.1186/s12974-020-01822-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
33 Czubowicz K, Jęśko H, Wencel P, Lukiw WJ, Strosznajder RP. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders. Mol Neurobiol 2019;56:5436-55. [PMID: 30612333 DOI: 10.1007/s12035-018-1448-3] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 22.7] [Reference Citation Analysis]
34 Wang L, Zhang L. Circulating Exosomal miRNA as Diagnostic Biomarkers of Neurodegenerative Diseases. Front Mol Neurosci 2020;13:53. [PMID: 32351363 DOI: 10.3389/fnmol.2020.00053] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 15.0] [Reference Citation Analysis]
35 Toivonen JM, Sanz-Rubio D, López-Pérez Ó, Marín-Moreno A, Bolea R, Osta R, Badiola JJ, Zaragoza P, Espinosa JC, Torres JM, Martín-Burriel I. MicroRNA Alterations in a Tg501 Mouse Model of Prion Disease. Biomolecules 2020;10:E908. [PMID: 32549330 DOI: 10.3390/biom10060908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Laneve P, Tollis P, Caffarelli E. RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective. Int J Mol Sci 2021;22:10285. [PMID: 34638636 DOI: 10.3390/ijms221910285] [Reference Citation Analysis]
37 Ricci C, Marzocchi C, Battistini S. MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis. Cells 2018;7:E219. [PMID: 30463376 DOI: 10.3390/cells7110219] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 10.5] [Reference Citation Analysis]
38 Kos MZ, Puppala S, Cruz D, Neary JL, Kumar A, Dalan E, Li C, Nathanielsz P, Carless MA. Blood-Based miRNA Biomarkers as Correlates of Brain-Based miRNA Expression. Front Mol Neurosci 2022;15:817290. [DOI: 10.3389/fnmol.2022.817290] [Reference Citation Analysis]
39 Nuzziello N, Liguori M. Seeking a standardized normalization method for the quantification of microRNA expression. Muscle Nerve 2019;59:E39. [PMID: 30809823 DOI: 10.1002/mus.26455] [Reference Citation Analysis]
40 Ludwig N, Fehlmann T, Kern F, Gogol M, Maetzler W, Deutscher S, Gurlit S, Schulte C, von Thaler AK, Deuschle C, Metzger F, Berg D, Suenkel U, Keller V, Backes C, Lenhof HP, Meese E, Keller A. Machine Learning to Detect Alzheimer's Disease from Circulating Non-coding RNAs. Genomics Proteomics Bioinformatics 2019;17:430-40. [PMID: 31809862 DOI: 10.1016/j.gpb.2019.09.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 9.7] [Reference Citation Analysis]
41 Wang X, Zhou Y, Gao Q, Ping D, Wang Y, Wu W, Lin X, Fang Y, Zhang J, Shao A. The Role of Exosomal microRNAs and Oxidative Stress in Neurodegenerative Diseases. Oxid Med Cell Longev 2020;2020:3232869. [PMID: 33193999 DOI: 10.1155/2020/3232869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
42 Dowling L, Duseja A, Vilaca T, Walsh JS, Goljanek-Whysall K. MicroRNAs in obesity, sarcopenia, and commonalities for sarcopenic obesity: a systematic review. J Cachexia Sarcopenia Muscle 2022;13:68-85. [PMID: 34984856 DOI: 10.1002/jcsm.12878] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
43 Perdaens O, Dang HA, D'Auria L, van Pesch V. CSF microRNAs discriminate MS activity and share similarity to other neuroinflammatory disorders. Neurol Neuroimmunol Neuroinflamm 2020;7:e673. [PMID: 32033981 DOI: 10.1212/NXI.0000000000000673] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
44 Xue X, Wang C, Xue Z, Wen J, Han J, Ma X, Zang X, Deng H, Guo R, Asuquo IP, Qin C, Wang H, Gao Q, Liu S, Wang J. Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma. Acta Biochim Biophys Sin (Shanghai) 2020;52:281-93. [PMID: 32073597 DOI: 10.1093/abbs/gmz164] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
45 García-Fonseca Á, Martin-Jimenez C, Barreto GE, Pachón AFA, González J. The Emerging Role of Long Non-Coding RNAs and MicroRNAs in Neurodegenerative Diseases: A Perspective of Machine Learning. Biomolecules 2021;11:1132. [PMID: 34439798 DOI: 10.3390/biom11081132] [Reference Citation Analysis]
46 Pansarasa O, Garofalo M, Scarian E, Dragoni F, Garau J, Di Gerlando R, Diamanti L, Bordoni M, Gagliardi S. Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis. Int J Mol Sci 2022;23:2580. [PMID: 35269723 DOI: 10.3390/ijms23052580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Nuzziello N, Craig F, Simone M, Consiglio A, Licciulli F, Margari L, Grillo G, Liuni S, Liguori M. Integrated Analysis of microRNA and mRNA Expression Profiles: An Attempt to Disentangle the Complex Interaction Network in Attention Deficit Hyperactivity Disorder. Brain Sci 2019;9:E288. [PMID: 31652596 DOI: 10.3390/brainsci9100288] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
48 Chen Y, Chen S, Lu J, Yuan D, He L, Qin P, Tan H, Xu L. MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B. Medicine (Baltimore) 2021;100:e25807. [PMID: 33950983 DOI: 10.1097/MD.0000000000025807] [Reference Citation Analysis]
49 Joilin G, Leigh PN, Newbury SF, Hafezparast M. An Overview of MicroRNAs as Biomarkers of ALS. Front Neurol. 2019;10:186. [PMID: 30899244 DOI: 10.3389/fneur.2019.00186] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
50 Mu J, Cheng X, Zhong S, Chen X, Zhao C. Neuroprotective effects of miR-532-5p against ischemic stroke. Metab Brain Dis 2020;35:753-63. [PMID: 32086725 DOI: 10.1007/s11011-020-00544-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
51 Chen QY, Wen T, Wu P, Jia R, Zhang R, Dang J. Exosomal Proteins and miRNAs as Mediators of Amyotrophic Lateral Sclerosis. Front Cell Dev Biol 2021;9:718803. [PMID: 34568332 DOI: 10.3389/fcell.2021.718803] [Reference Citation Analysis]
52 Kim G, Chen X, Yang Y. Pathogenic Extracellular Vesicle (EV) Signaling in Amyotrophic Lateral Sclerosis (ALS). Neurotherapeutics. [DOI: 10.1007/s13311-022-01232-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Baumert B, Sobuś A, Gołąb-Janowska M, Ulańczyk Z, Paczkowska E, Łuczkowska K, Zawiślak A, Milczarek S, Osękowska B, Meller A, Machowska-Sempruch K, Wełnicka A, Safranow K, Nowacki P, Machaliński B. Local and Systemic Humoral Response to Autologous Lineage-Negative Cells Intrathecal Administration in ALS Patients. Int J Mol Sci 2020;21:E1070. [PMID: 32041109 DOI: 10.3390/ijms21031070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
54 Catanesi M, d'Angelo M, Tupone MG, Benedetti E, Giordano A, Castelli V, Cimini A. MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases. Int J Mol Sci 2020;21:E5986. [PMID: 32825273 DOI: 10.3390/ijms21175986] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
55 Madadi S, Soleimani M. Study of serum microrna expression in an amyotrophic lateral sclerosis patient: Challenge of selecting suitable internal control for normalization. Muscle Nerve 2019;59:E2-3. [PMID: 30383294 DOI: 10.1002/mus.26370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 Alvia M, Aytan N, Spencer KR, Foster ZW, Rauf NA, Guilderson L, Robey I, Averill JG, Walker SE, Alvarez VE, Huber BR, Mathais R, Cormier KA, Nicks R, Pothast M, Labadorf A, Agus F, Alosco ML, Mez J, Kowall NW, Mckee AC, Brady CB, Stein TD. MicroRNA Alterations in Chronic Traumatic Encephalopathy and Amyotrophic Lateral Sclerosis. Front Neurosci 2022;16:855096. [DOI: 10.3389/fnins.2022.855096] [Reference Citation Analysis]
57 Gámez-Valero A, Campdelacreu J, Vilas D, Ispierto L, Reñé R, Álvarez R, Armengol MP, Borràs FE, Beyer K. Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer's disease and dementia with Lewy bodies. Transl Neurodegener 2019;8:31. [PMID: 31592314 DOI: 10.1186/s40035-019-0169-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 13.0] [Reference Citation Analysis]
58 Catapano F, Scaglioni D, Maresh K, Ala P, Domingos J, Selby V, Ricotti V, Phillips L, Servais L, Seferian A, Groot I, Krom YD, Voit T, Verschuuren JJGM, Niks EH, Straub V, Morgan J, Muntoni F. Novel free-circulating and extracellular vesicle-derived miRNAs dysregulated in Duchenne muscular dystrophy. Epigenomics 2020;12:1899-915. [PMID: 33215544 DOI: 10.2217/epi-2020-0052] [Reference Citation Analysis]
59 Rahman MR, Islam T, Huq F, Quinn JM, Moni MA. Identification of molecular signatures and pathways common to blood cells and brain tissue of amyotrophic lateral sclerosis patients. Informatics in Medicine Unlocked 2019;16:100193. [DOI: 10.1016/j.imu.2019.100193] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 3.7] [Reference Citation Analysis]